Newsletter | December 12, 2020

12.12.20 -- Six API Challenges And How To Avoid Them

Industry Insights
Six API Challenges And How To Avoid Them

Having a solid understanding of the most common API challenges can help to avoid development delays, rework, or outright failure.

Trends In Protein Separation And Analysis — The Advance Of Stain-Free Technology

Stain-free technology, a technology that existed in principle since early 2000 but was only commercialized in 2010 has changed the protein separation and analysis landscape in the past few years. This article focuses on how protein visualization is accomplished using stain-free technology, its advantages and concerns as well as how stain-free technology can change the way we carry out protein separation and analysis.

High-Loaded Dosage Forms: Novel Platform Expands Dispersion Utility

Spray-dried amorphous solid dispersions (ASDs) show enormous promise in the delivery of drug compounds with low solubility. A novel platform expands the utility of this approach to meet patient needs.

Are You Prepared For The Complexity Of Pediatric Drug Development?

Pediatric drug development requires a formulation designed to fit the specific needs of that patient population. Not considering these requirements early enough could add significant delays.

Western Blot Detection: Is Film Or A Digital CCD Imager Better?

Learn the benefits and drawbacks of using film or a CCD imager to detect the bound antibody in Western blotting, also known as immunoblotting.

Tufts Study: Advantages Of Single-Source Drug Development, Manufacturing

A recent study by the Tufts Center for the Study of Drug Development (CSDD) compared cycle times and development economics between multi- and single-source CDMO models.

Leveraging Innovative Technologies, Best Practices And Strategies To Accelerate Biologics Development And Commercialization

Gain insight into how practical implementation of innovative technologies and solutions such as multi-attribute method, modernized cell line development workflow using high-yield cell lines and automated systems, as well as next generation purification resins help to accelerate biologics development and commercialization.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.